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To evaluate the impact of a mild increment in blood
pressure level on endothelial function, we evaluated 61
healthy volunteers (24 women, 37 men, and aged 35–50
years). All subjects underwent a blood chemistry panel
to exclude any metabolic abnormalities and were sub-
mitted to a Doppler ultrasound of the brachial artery to
assess endothelial function. We assessed the endothe-
lial response to reactive hyperaemia and exogenous
nitric oxide administration considering an increase in
systolic blood pressure (SBP) at each 10-mm Hg interval.
Our study population was divided as follows:
SBP o115 mm Hg (SG1, n¼ 13), SBP X115 mm Hg
and o125 mm Hg (SG2, n¼ 20), SBP X125 mm Hg and
o135 mm Hg (SG3, n¼ 13) and SBP X135 mm Hg and
o140 mm Hg (SG4, n¼ 15). We found a significant
difference in flow-mediated dilation among SG2, SG3
and SG4, 16.275.6, 13.475.2 and 11.573.6%, Po0.05,
respectively). After nitrate administration, we observed
a nonsignificant decrease in brachial artery dilation
among groups, P¼ 0.217. Our data showed in a healthy
normotensive population, without any risk factor for
atherosclerotic disease that small increases in SBP but
not in diastolic blood pressure may impair endothelial
function even in subjects considered as high-normal,
meaning that this population deserves more attention
than usually ascribed to intervene and prevent complica-
tions, as endothelial dysfunction may represent an early
change in those who develop hypertension later in life.
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Introduction
The impact of blood pressure levels on cardiovas-
cular complications is more and more frequently
reported in epidemiological as well as in interven-
tional studies. Recently, the VII Joint National
Committee (JNC VII) published in May 2003,
pointed out that ‘ythe risk of cardiovascular
diseases (CVD) beginning at 115/75 mm Hg doubles
with each increment of 20/10 mm Hgy’ and those
individuals previously categorized as high-normal
(HN), that is, systolic blood pressure (SBP) between
130–139 mm Hg and/or diastolic blood pressure
between 85 and 89 mm Hg should be considered as
prehypertensives, requiring lifestyle changes to
prevent CVD.1 Although not accepted by all inter-
national guidelines, this new classification led to
some considerations regarding the structural and
functional changes presented by these individuals
with HN blood pressure levels.
The relationship between blood pressure levels
and cardiovascular events, such as stroke, heart
failure and myocardial infarction are well known as
a continuum; thus, the higher the blood pressure the
greater the chance of cardiovascular complications.
The Framingham study showed an increased risk
of 1.6 in men and 2.8 in women in HN individuals
compared with individuals with optimal blood
pressure levels for cardiovascular events during
a 12-years follow-up.2
It is also known that one of the earliest changes
observed in hypertensive subjects, either in stage 1
of hypertension or in normotensive (NT) subjects
with a family history of hypertension is an impaired
endothelial response to reactive hyperaemia.3–6
Previous data from our group have detected
a graded impairment in vasodilatatory response
from NT healthy subjects compared to smokers,
hypertensive and those with hypertension and
diabetes mellitus, suggesting that not only blood
pressure levels but the presence or coexistence of
other risk factors may decrease this vasodilatatory
response.7
Endothelial dysfunction was initially described
as a lack in nitric oxide (NO) release and/or excess
of free radicals, suggesting an imbalance between
vasodilators and vasoconstrictor agents present at
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endothelial cells (functional change). Once hyper-
tension is established, there is also impairment in
non-endothelium-dependent vasodilatatory response
probably owing to structural changes in blood
vessels. Several studies have been developed to
evaluate these changes by a non-invasive methodol-
ogy described by Celermajer,8 the brachial artery by B
mode ultrasound, which is safe and reliable.
Thus, considering the data shown in JNC VII
based on a meta-analysis of 61 observational studies,
and considering data from scientific literature that
provides a support in the evaluation of endothelial
response to different stimuli, our study aimed to
assess the endothelium-dependent (flow-mediated
dilation (FMD)) and non-endothelium dependent
(nitrate-mediated dilation (NMD)) vasodilatatory
response in NT and HN subjects. Second, we
divided blood pressure levels in a 10-mm Hg
interval for both, systolic and diastolic blood
pressure (SBP), to investigate the brachial artery
dilation through a non-invasive method using B
mode ultrasound.
Patients and methods
This study had a cross-sectional design and the
study population consisted of 61 healthy volunteers
of both sexes (24 women, 37 men, aged 35–50 years)
recruited from the community. None of them were
smokers, or had a previous history of hypertension,
dislipidemia, diabetes mellitus or any other clinical
condition that might be considered as a confounder
in the interpretation of the results. There were two
groups: NT subjects (n¼ 33) who had normal blood
pressure levels (o120/80 mm Hg) and HN subjects
(n¼ 28) defined as a SBP between 130 and 139 mm
Hg and/or diastolic blood pressure between 85 and
89 mm Hg. All subjects were informed on study
purposes and after they signed an informed consent
they came to the office for study procedures
including blood pressure measurement and deter-
mination of weight and height to further calculate
body mass index. At this visit they also had blood
sample drawn after 10 h of overnight fasting from
antecubital vein for blood chemistry analyses to
confirm the absence of any metabolic abnormalities
that might influence the interpretation of the tests.
A 12-lead electrocardiogram was also performed.
Following these tests, all subjects were scheduled to
perform a Doppler ultrasound of the brachial artery
to assess endothelial response. Endothelial function
was assessed in the next day after confirmation of
their eligibility after a 10 h of overnight fast. This
study was submitted to the Ethics Committee of the
Hospital Sa˜o Paulo; Federal University of Sa˜o Paulo
under protocol # 360/00.
Methods
Blood pressure measurement. Blood pressure
levels were determined after 10 min of rest in sitting
position using a standard mercury sphygmomano-
meter. Blood pressure levels were measured three
times within a 1-min interval. Following these
measurements, subjects assumed the upright posi-
tion and after 2 min their blood pressure was
measured once. The same physician performed
these measurements. The average of the three values
obtained in sitting position was used in the
subsequent analyses. Systolic and diastolic blood
pressure corresponded to phases I and V of Korotk-
off sound, respectively.
Biochemistry. The tests performed were as
follows: fasting serum glucose, total cholesterol,
high-density lipoprotein-cholesterol, low-density
lipoprotein-cholesterol and triglycerides, serum
creatinine. All blood tests were performed at the
Central Laboratory of the Hospital do Rim e
Hipertensa˜o. Cholesterol levels were determined
using Bio-Chromatic analyser series II-F from Ab-
bott, and normal range was based on the Brazilian
Guidelines of Dyslipidemia, 1994. Serum creatinine
was determined by Jaffe´ technique and fasting
glucose by orthotoluidine method.
Brachial artery B mode ultrasound. The endothe-
lial function test was performed by high-resolution
B-mode ultrasound images using a non-invasive
methodology described by Celermajer et al.3 with
modifications.9 The equipment used in this study
was an Ultramark HDI 3000 (ATL ultrasound
incorporation), with a linear transducer of L7–
4 MHz. The test consisted of four phases as follow:
rest, after reactive hyperaemia (endothelium-depen-
dent phase – FMD), again with the subject at rest,
and finally, and after administration of sublingual
nitrate (endothelium-independent phase – NMD).
All measurements were performed in the same
place, in longitudinal section 5–10 cm above the
antecubital fossa of the right upper arm.
At the end of the first phase of resting when
a satisfactory position was found to carry on the
endothelial study, the skin was marked and the arm
remained in the same position throughout the test.
At this moment, the diameter and blood flow
velocity were determined in triplicate for the first
phase. To obtain an increased flow, a cuff was
placed on the right upper arm and it was inflated to
300 mm Hg, resulting in a complete interruption of
blood flow during a 5-min period, and then the cuff
was deflated. A second and third scan were
obtained after 15 and 90 s after the cuff was released
(known as reactive hyperaemia phenomenon that
was followed by a brachial FMD. The maximum
blood flow (mm/min) was determined in the first
15 s after the cuff release. Ninety seconds after
ischaemia, three measurements of the diameter of
the brachial artery were taken at the diastolic period
(FMD). A 10-min of rest was then allowed for
recovery of the vessel and at the end of this period
a sublingual tablet of isossorbide dinitrate 5.0 mg,
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was given to the subjects. Five minutes after
isossorbide dinitrate administration three measure-
ments were obtained for brachial artery diameter
and blood flow velocity to determine nitrate-
induced vasodilation of the arterial wall (known as
endothelium-independent vasodilation). The mean
of these values was used in subsequent analyses.
FMD response was expressed as the change in end-
diastolic diameter of the brachial artery during
reactive hyperaemia compared with the baseline
(rest) measurement and used as a measure of
endothelium-dependent vasodilation. The mean of
these values were used in subsequent analyses.
To determine the confidence of the results,
vascular tests (vasodilation after reactive hyperae-
mia and nitrate-stimulated dilation) were performed
by two independent observers in 10 healthy volun-
teers. Intra- and interobserver variability for re-
peated measurements of the same recording of the
brachial artery diameter was 2.1671.7, 2.4171.9
and 6.774.0%, respectively.
Data analysis
Statistical plan. To assess the endothelial response
after the initial analysis (NT vs HN group), we
divided the study population according to a 20-mm
Hg interval for SBP and 10-mm Hg for diastolic
blood pressure. A final analysis was carried out in
the study population considering at this time a
10-mm Hg interval for SBP.
Statistical analysis
Data were stored and analyzed with SigmaStat for
Windows version 2.0, (Jandel Corporation, Chicago).
Data are expressed as mean7s.d. or median and
its confidence intervals and comparison were made
by using Student’s t-test and analysis of variance.
Statistical significance was considered for differ-
ences when the two-tailed P-value was less
than 0.05.
Results
Subjects (24 women and 37 men) had a mean age
of 41.874.7 years (range, 35–50). Table 1 shows
demography, clinical and laboratorial values in both
groups, NT and HN subjects. Except for a statistical
difference in mean body weight in HN subjects,
no other statistically significant differences were
observed between the two groups.
Although we had more women in NT group
(n¼ 16) than in HN group (n¼ 8), we did not find
any statistically significant difference in age
(42.374.4 vs 44.773.6 years, NS), post-menopausal
or childbearing potential status as well as in any
variable assessed in this study. Among all laborator-
ial parameters evaluated, we did not observe a
statistically significant difference, except for serum
creatinine levels, where men showed a higher level
of serum creatinine than women (P¼ 0.0015).
Normotensive versus high-normal subjects
Flow-mediated vasodilation. The mean FMD in
brachial artery following reactive hyperaemia in NT
group (n¼ 33) was 13.978.2%, whereas in HN
(n¼ 28) subjects the mean dilation was 9.877.0%,
which was a statistically significant difference
(Po0.05), as shown in Figure 1. The percentual
change in FMD in HN subjects compared to HN was
29.5% lower.
When we compared the results according to sex,
women showed a greater vasodilation 14.578.0%
than men 10.477.5 (Po0.05).
Nitrate-mediated dilation
The mean NMD of brachial artery after exogenous
nitrate administration in NT group (n¼ 33) was
13.878.1% whereas in HT (n¼ 28) subjects, NMD
was slightly lower, 11.175.6% and represented a
percent change of 19.5%, although this difference
did not reach statistical significance.
When the pooled data were compared to each sex,
we did not find any difference: 12.577.2% (pooled
data), 12.577.5 and 12.677.1, women and men,
respectively.
Blood pressure intervals
20-mm Hg interval in SBP. To analyze the impact
of blood pressure interval in FMD, we divided the
whole group irrespective of sex, considering an
interval of 20 mm Hg in SBP starting from a cutoff
value of 115 mm Hg, thus obtaining a group where
SBP X115 mm Hg and o135 mm Hg (GI, n¼ 33),
and a second group with a SBP X135 mm Hg but
o140 mm Hg (GII, n¼ 15). The remaining 13
subjects had SBP values p115 mm Hg and were
not considered in this analysis. The endothelium-
dependent vasodilation response in GI showed a
Table 1 Clinical and demographic characteristics of NT and HN
groups
Variables/groups NT subjects
(n¼ 33)
HN subjects
(n¼ 28)
Sex 17 M/16 F 20 M/8 F
Age (years) 41.674.6 42.074.7
Weight (kg) 67.478.2 77.6715.4*
Height (m) 1.6570.07 1.7070.10
BMI (kg/m2) 24.772.1 26.873.5
SBP (mm Hg) 11477 13475*
DBP (mm Hg) 7577 8375*
FPG (mg/dl) 87.6710.6 88.678.9
Creatinine (mg/dl) 0.9270.18 0.9770.14
Total cholesterol (mg/dl) 187.2723.4 181.4724.3
LDL-cholesterol(mg/dl) 120.6727.3 114.5727.4
HDL-cholesterol (mg/dl) 49.0711.3 46.778.5
Triglycerides (mg/dl) 110.0748.4 133.2751.3
*Po0.05 versus normotensives.
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure;
FPG, fasting plasma glucose; HDL-cholesterol, high-density lipopro-
tein cholesterol; HN, high-normal; LDL-cholesterol, low-density
lipoprotein cholesterol; NT, normotensive; SBP, systolic blood
pressure.
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trend towards a higher response 15% (9.75–20.00)
when compared to GII 11% (8.0–14.25), P¼ 0.059.
Figure 2 show the vasodilation response in both
groups. The impact in NMD at 20-mm Hg interval
did not show any statistical difference between
groups.
10-mm Hg interval for SBP. We also performed an
analysis considering an interval of 10 mm Hg in SBP
to test the vascular response to endothelial stimuli.
Subjects were divided in the following subgroups:
SBP o115 mm Hg (SG1, n¼ 13), SBP X115 mm Hg
and o125 mm Hg (SG2, n¼ 20), SBP X125 mm Hg
and o135 mm Hg (SG3, n¼ 13) and SBP X135 mm
Hg and o140 mm Hg (SG4, n¼ 15). There was a
statistically significant difference in FMD among
the three subgroups, 16.275.6, 13.475.2 and
11.573.6%, SG2, SG3 and SG4, respectively) as
shown in Figure 3. SG1 subjects showed a FMD
of 12.678.8%.
When we compared the four subgroups regarding
NMD, we did not observe any significant change in
brachial artery dilation, as follows: 15.978.0,
14.876.5, 12.574.8 and 11.575.0%, respectively,
P¼ 0.217).
10-mm Hg interval in diastolic blood pressure.
Taking into account a 10-mm Hg interval for
diastolic blood pressure, we did not detect differ-
ences in vessel diameter related to endothelium-
dependent or-independent stimuli. Data are shown
in Table 2.
Discussion
Our data showed in a healthy population with no
risk factors for atherosclerotic disease that SBP
assessed at 10- or 20-mm Hg intervals, but not
diastolic blood pressure predisposed subjects to
endothelial dysfunction, compromising vascular
dilation.
It is well known that FMD reflects the relaxation
of a vessel exposed to increased shear stress. On
the other hand, the lack of response observed in
endothelium-independent vasodilation, that is, a
NMD may be explained by the fact that our subjects
were NTs or had HN blood pressure levels, and
probably these changes were not yet sufficient to
promote a vascular smooth muscle dysfunction.
This impact was noted in the two different
analyses, where within a 20-mm Hg interval for
SBP there was a 26.7% reduction in vasodilatatory
response, and within 10-mm Hg interval for SBP,
we found a progressive and significant reduction of
17.3% (from SG2 to SG3) and an additional 14.2%
(from SG3 to SG4) in vasodilatatory response as
blood pressure raised, suggesting that a person with
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Figure 1 FMD in NT (n¼33) and HN subjects (HN, n¼28).
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Figure 2 FMD following a 20 mm Hg increment in SBP.
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Figure 3 FMD following a 10-mm Hg interval in SBP.
Table 2 Changes in brachial artery diameter after endothelium-
dependent or independent stimuli with a 10 mm Hg increment in
diastolic blood pressure
Parameter
(%)
o75 mm Hg
(n¼ 17)
75–85 mm
Hg (n¼ 35)
85–90
(n¼9)
FMD 13.979.3 12.776.1 10.078.5
NMD 13.276.9 13.177.6 10.675.2
Data expressed as mean7s.d. or median and its confidence interval.
Abbreviations: FMD, flow-mediated dilation; NMD, nitrate-mediated
dilation.
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no other risk factor for cardiovascular disease,
presenting a SBP within the range of 125–135 mm
Hg, which is considered adequate in clinical
practice is, indeed, exposed to a greater risk of
vascular damage later in life specially if he/she
becomes hypertensive and is also predisposed to an
earlier atherosclerotic process.
However, the most relevant finding was related to
the 10-mm Hg interval, which allowed us to detect
impairment in vasodilation. Comparing SG2 to SG4,
there was a marked reduction in vasodilatatory
capacity of 29%.
Our data are consistent with previous results from
literature, which suggest the presence of endothelial
dysfunction as a paraphysiological status of ‘pre-
hypertension’.10 This assumption is corroborated by
the findings in a prospective study involving more
than 5000 subjects where those with prehyperten-
sion had an increased risk of coronary heart disease
and myocardial infarction which was related to SBP
level but not with diastolic.11
Another study using ABPM showed that NT
subjects with endothelial dysfunction presented
a higher 24-h blood pressure values, which is the
reflex of consistent changes in the organisation of
blood pressure circadian pattern probably related to
vasopressor effects even in NT subjects.12 There are
some aspects that should be mentioned such as the
impact of haemodynamic forces on arterial wall
leading to damage and earlier atherosclerotic
process that may be detected even in NT subjects,
genetic predisposition and metabolic profile, which
may individually or in association, play a role in the
development of atherosclerosis. Also, in a popula-
tion-based cohort study (NOMAS), the authors
found a significant association between endothelial
dysfunction and the presence of carotid plaque and
this FMD impairment was more relevant among
subjects with carotid plaques thicker than 2 mm,
which in turn, was associated with a higher
cardiovascular risk.13
In a meta-regression analysis, Witte et al.14 re-
ported a clearer relation between FMD and the
principal cardiovascular risk factors only in the
category with the lowest cardiovascular baseline
risk, and found no relation in middle and high-risk
populations. The authors considered that such
difference among low-, middle- and high-risk popu-
lations could be partially explained by the fact that
the endothelium ability to produce NO was affected
at the initial stages of the atherosclerotic process,
and beyond this point there could be no additional
impairment in FMD.
The impact of body weight on endothelial func-
tion has been shown in literature15,16 mainly when
subjects are submitted to weight loss interventions
such as bariatric surgery, dietary or exercise mod-
ifications, although some authors suggested that this
impact is better observed among women than in
men.17 We did not find any impact on FMD related
to body weight both in NT and HN subjects as
assessed by Pearson’s correlation (r¼0.20 and
r¼ 0.10, for FMD and NMD, P40.05, respectively)
in NT subjects and (r¼0.10 and r¼ 0.29 for FMD
and NMD, P40.05, respectively) in HN subjects.
In both groups, most women were not overweight
or obese and this may at least in part explain
our finding.
Therefore, the relevance of our findings is the fact
that for the first time it was shown that in a healthy
population, within a graded level of blood pressure
interval, it could be possible to detect an early
impairment in vasodilation, or in other words, in the
ability of vessel relaxation, and it should be taken
into account as a possible cardiovascular risk marker
assessed by a non-invasive method.
In summary, our data point out the need that in
this population more attention than usually should
be ascribed, to intervene and prevent complications
later in life.
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